Ukuthatha i-Vimovo Yokuphatha I-Arthritis

Inhlanganisela yeNaproxen ne-PPI

I-Vimovo, eyakhiwe yiPozen no-AstraZeneca, iyinhlanganisela ye naproxen (i-NSAID) kanye ne-esomeprazole ngokushesha (i- proton-pump inhibitor , noma i-PPI). Ukwakhiwa ngokushesha kokukhulula kuvumela ukukhululwa okulandelanayo kwezingxenye ezisebenzayo-esomeprazole kuhanjiswa kusengaphambili kokukhululwa kwe-naproxen. I-Vimovo yamukelwa yi-FDA ngo-Ephreli 30, 2010.

Ukutholakala

I-Vimovo itholakale kuphela nge-odokotela. I-Vimovo iyatholakala ngamandla amabili-i-esomeprazole engu-20 mg ehlanganiswe no-375 mg noma i-naproxen engu-500 mg-okufanele ithathwe ngomlomo. Imithi evamile yokwelapha i- osteoarthritis , i- arthritis ye-rheumatoid , noma i- spondylitis e-ankylosing i-tablet eyodwa kabili ngosuku nge-Vimovo 375 mg naproxen / 20 mg esomeprazole noma 500 mg naproxen / 20 mg esomeprazole.

Ngabe i-Vimovo ibhalwe nini?

I-Vimovo inqunyelwe ukusizwa kwezibonakaliso nezimpawu ze-osteoarthritis, i-rthumicid arthritis, i-anondlosing spondylitis nokunciphisa ingozi yokuthuthukisa izilonda zesisu esiswini ezingozini yokuthuthukisa izilonda zesisu ezihambisana ne-NSAID.

Imiyalo Ekhethekile

I-Vimovo, njengabo bonke ama-NSAID, kufanele kuthathwe ngokuqondile njengoba kunqunywe umthamo ophansi kakhulu ongasebenza futhi isikhathi esifushane esidingekayo ukuze unciphise ingozi yemiphumela emibi. Kumele uthathe i-Vimovo okungenani imizuzu engu-30 ngaphambi kokudla.

I-Vimovo kumele igonywe ngokuphelele. Ungadli, uhlukanise, uqhekeze, noma uchithe i-Vimovo. Uvunyelwe ukuthatha ama-antacids uma kudingeka uma uthatha i-Vimovo.

Zikhona Iziguli Okungafanele Zithathe Vimovo?

Ayaziwa ukuthi i-Vimovo iphephile noma iyasebenza kubantu abangaphansi kweminyaka engu-18 ubudala. Futhi, abantu abaye bahlaselwa yisifo se-asthma, imifantu, noma ezinye izifo ezithathelanayo ngenkathi bethatha i-aspirin noma amanye ama-NSAID akufanele athathe i-Vimovo.

Uma wazi izidakamizwa kunoma yimaphi izithako ku-Vimovo noma i-proton pump inhibitor, akufanele uthathe i-Vimovo. I-Vimovo akufanele ithathwe ngaphambi noma emva kokuhlinzwa kwe-coronary bypass. Lesi sidakamizwa asikhuthazwa nakwabesifazane ku-trimester yabo yesithathu yokukhulelwa.

Okuqhamuka uma udla imishanguzo

Eminye imiphumela emibi ejwayelekile engahlotshaniswa neVimovo ihlanganisa:

Imiphumela emibi ingabandakanya ukucindezeleka okukhulu kwegazi, ukuhlasela kwenhliziyo, ukushaywa umoya, ukugcinwa kwamanzi, izinkinga zezinso, izilonda eziphaphayo, i-anemia, ukusabela kwesikhumba esasongela ukuphila nokubhekana nokugula, izinkinga zesibindi nokuhlaselwa kwesifo se-asthma.

Ezinye izixwayiso ezikhethekile kanye nokuqapha

Ingozi yezilonda eziphaphayo ezihlobene neVimovo nezinye izinsizakalo ze-NSAID zanda uma uthatha i-corticosteroids noma i-blood thinners, umusi, uphuze utshwala, usempilweni embi, noma usekhulile.

Ukusebenzisana kwezidakamizwa

Kungase kube nokusebenzisana kwezidakamizwa nama-ACE-inhibitors, i-aspirin, i-cholestyramine, i-diuretics, i-lithium, i- methotrexate , i-anticoagulants, kanye ne-serotonin e-reuptake inhibitors ekhethiwe.

Imiyalo yabesifazane abakhulelwe noma abahlengikazi

I-Vimovo kufanele igwenywe ngesikhathi sokugcina sokukhulelwa. Ngokuphathelene nokuncelisa, i-Vimovo ingadlula ubisi lwebele futhi mhlawumbe ilimaze ingane.

Gwema i-Vimovo uma uhlela ukuncelisa.

Izimpawu zokudlula ngaphezulu

Ukudlula ngokweqile kwe-Vimovo kungabangela ubuthakathaka, ukhathala, ubuhlungu obuphezulu besisu, ushintsho ekuphefumuleni, ukuhlanza, ukuphuma, ukunyakaza okungalawulwayo, nezinkinga zokuxhumana.

Imithombo:

Vimovo. Umhlahlandlela Wezokwelapha. I-FDA. Kubuyekezwe 3/2014.

Vimovo. Ulwazi lokubekezela.